
Diederik Stadig
economistMale0.0Global Dominance: 0.00%
Diederik Stadig is a health care sector economist for ING, focusing on the implications of economic policies on the pharmaceutical industry. He has analyzed how tariffs can impact drug prices and the accessibility of medications for consumers.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Diederik Stadig, health care sector economist for ING, wrote in a post last week.
Here’s what’s about to become more expensive with the next round of tariffsCNN·
United States· 2025-04-15
Diederik Stadig wrote about the conflicting policy goals for Trump regarding pharmaceuticals.
The next round of Trump’s tariffs could hurt even more. Here’s what to expectCNN·
United States· 2025-04-09










